Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matilde Cacciatore

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Blood|September 8, 2012
Stromal SPARC contributes to the detrimental fibrotic changes associated with myeloproliferation whereas its deficiency favors myeloid cell expansionClaudio Tripodo, Sabina Sangaletti, Carla Guarnotta, et al.
Oncotarget|April 21, 2016
Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumorsSabrina Rossi, Marta Sbaraglia, Marta Campo Dell'Orto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2025
Prognosis and biological characteristics of ER-low metastatic breast cancer: results from a multicenter cohort and the TONIC trialFederica Miglietta, Manon De Graaf, Claudio Vernieri, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Blood|September 8, 2012
Stromal SPARC contributes to the detrimental fibrotic changes associated with myeloproliferation whereas its deficiency favors myeloid cell expansionClaudio Tripodo, Sabina Sangaletti, Carla Guarnotta, et al.
Oncotarget|April 21, 2016
Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumorsSabrina Rossi, Marta Sbaraglia, Marta Campo Dell'Orto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2025
Prognosis and biological characteristics of ER-low metastatic breast cancer: results from a multicenter cohort and the TONIC trialFederica Miglietta, Manon De Graaf, Claudio Vernieri, et al.
Pageof 3